GB Patent

GB9925962D0 — Organic compounds

Assigned to Novartis AG · Expires 1999-12-29 · 26y expired

What this patent protects

Oral dosage forms comprising oxcarbazepine which when administered to a patient display no food effect.

USPTO Abstract

Oral dosage forms comprising oxcarbazepine which when administered to a patient display no food effect.

Drugs covered by this patent

oxcarbazepine (OXCARBAZEPINE)

Patent Metadata

Patent number: GB9925962D0
Jurisdiction: GB
Classification: —
Expires: 1999-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.